A detailed history of Jennison Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jennison Associates LLC holds 6,947,395 shares of LLY stock, worth $5.33 Billion. This represents 3.84% of its overall portfolio holdings.

Number of Shares
6,947,395
Previous 7,232,988 3.95%
Holding current value
$5.33 Billion
Previous $6.55 Billion 6.01%
% of portfolio
3.84%
Previous 4.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $221 Million - $274 Million
-285,593 Reduced 3.95%
6,947,395 $6.15 Billion
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $169 Million - $212 Million
-233,514 Reduced 3.13%
7,232,988 $6.55 Billion
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $77.6 Million - $104 Million
-131,110 Reduced 1.73%
7,466,502 $5.81 Billion
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $425 Million - $501 Million
-810,001 Reduced 9.63%
7,597,612 $4.43 Billion
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $75.6 Million - $104 Million
-173,825 Reduced 2.03%
8,407,613 $4.52 Billion
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $2.55 Million - $3.41 Million
7,274 Added 0.08%
8,581,438 $4.02 Billion
Q1 2023

Apr 26, 2023

SELL
$310.63 - $364.82 $576 Million - $677 Million
-1,854,917 Reduced 17.79%
8,574,164 $2.94 Billion
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $117 Million - $137 Million
364,339 Added 3.62%
10,429,081 $3.82 Billion
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $87 Million - $99.1 Million
-293,324 Reduced 2.83%
10,064,742 $3.25 Billion
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $685 Million - $804 Million
2,456,760 Added 31.09%
10,358,066 $3.36 Billion
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $294 Million - $366 Million
-1,254,308 Reduced 13.7%
7,901,306 $2.26 Billion
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $159 Million - $198 Million
-708,902 Reduced 7.19%
9,155,614 $2.53 Billion
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $211 Million - $260 Million
953,521 Added 10.7%
9,864,516 $2.28 Billion
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $627 Million - $811 Million
3,470,858 Added 63.8%
8,910,995 $2.05 Billion
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $585 Million - $758 Million
3,561,294 Added 189.55%
5,440,137 $1.02 Billion
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $352 Million - $466 Million
-2,701,830 Reduced 58.98%
1,878,843 $317 Million
Q3 2020

Nov 04, 2020

SELL
$146.22 - $169.13 $509 Million - $589 Million
-3,482,699 Reduced 43.19%
4,580,673 $678 Million
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $290 Million - $349 Million
-2,128,680 Reduced 20.89%
8,063,372 $1.32 Billion
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $676 Million - $837 Million
5,679,574 Added 125.86%
10,192,052 $1.41 Billion
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $338 Million - $418 Million
3,157,292 Added 232.98%
4,512,478 $593 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $23.3 Million - $25.4 Million
-218,457 Reduced 13.88%
1,355,186 $152 Million
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $230 Million - $269 Million
-2,077,373 Reduced 56.9%
1,573,643 $0
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $25.1 Million - $29.6 Million
225,592 Added 6.59%
3,651,016 $474 Million
Q4 2018

Feb 06, 2019

BUY
$105.9 - $118.64 $136 Million - $152 Million
1,280,878 Added 59.73%
3,425,424 $396 Million
Q3 2018

Nov 08, 2018

BUY
$85.86 - $107.31 $20.8 Million - $26 Million
242,577 Added 12.75%
2,144,546 $230 Million
Q2 2018

Aug 02, 2018

BUY
$75.7 - $86.88 $626,190 - $718,671
8,272 Added 0.44%
1,901,969 $162 Million
Q1 2018

Apr 20, 2018

SELL
$74.21 - $87.6 $28.5 Million - $33.6 Million
-383,990 Reduced 16.86%
1,893,697 $147 Million
Q4 2017

Jan 25, 2018

BUY
$81.94 - $87.89 $22.2 Million - $23.8 Million
270,921 Added 13.5%
2,277,687 $192 Million
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $155 Million - $172 Million
2,006,766
2,006,766 $172 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.